Alphamab Oncology IPO: Valuation Easy to Swallow
Alphamab Co Ltd (9966 HK) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...
653 Views
ECM Weekly (1 Dec 2019) - Venus Medtech, Alphamab, CMC REIT, XD, BAM
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. It has...
694 Views
Alphamab (康宁杰瑞) IPO: You Will Likely Be Zeroed
Alphamab launched book building to raise up to USD 234 million to list in Hong Kong. In our previous notes, we covered the company’s key pipeline...
762 Views
Alphamab Oncology IPO Initiation: Clear Diagnosis
Alphamab Co Ltd (1728643D CH) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...
634 Views
Alphamab (康宁杰瑞) Pre-IPO: Promising Readings from PHIP Updates
Alphamab obtained approval from HKSE last week and started pre-marketing for its USD 200-300m deal this week. In our previous notes, we covered the...
610 Views